ArticleJournal of interventional medicine2021
Bronchial artery embolization for hemoptysis: A systematic review and meta-analysis.
Article in Journal of interventional medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.
- Predictors of Recurrence Following Bronchial Artery Embolisation (BAE) for Haemoptysis: A Systematic Review and Evidence Synthesis Analyses Using SWiM Guidelines.Cardiovascular and interventional radiology · 2026Pooled it
- Bronchial artery embolization versus conservative treatment for hemoptysis: a systematic review and meta-analysis.BMC pulmonary medicine · 2024Pooled it
- Advances and challenges in the management of haemoptysis in the emergency department: A narrative review.Lung India : official organ of Indian Chest Society · 2026Article
- Superselective Pulmonary Artery Embolization for Refractory Massive Hemoptysis Post-Bronchial Artery Embolization: A Bail-Out Measure.Cardiovascular and interventional radiology · 2026Article
- Risk Factors for the Recurrence of Massive Hemoptysis Treated With Bronchial Artery Embolization: A Retrospective Study.The clinical respiratory journal · 2026Article
- The hemodynamic and clinical characteristics of recurrent hemoptysis in bronchiectasis patients after vascular intervention procedures.Journal of thoracic disease · 2026Article
- Lung Adenocarcinoma With Intratumoral Necrosis Induced by Bronchial Artery Embolization.Respirology case reports · 2026Article
- Non-bronchial systemic arteries in massive hemoptysis secondary to pulmonary tuberculosis: risk factors and outcomes of embolization materials. A retrospective observational study.Frontiers in medicine · 2026Article
- Superselective bronchial artery embolization guided by bronchial artery CT angiography for pediatric hemoptysis and pulmonary hemorrhage: a retrospective single-center study.Frontiers in pediatrics · 2026Article
- Pediatric bronchial Dieulafoy's disease: a biopsy-sparing bronchoscopic approach with selective bronchial artery embolization.Frontiers in pediatrics · 2026Article
- Multidisciplinary collaborative treatment of a rare case of chronic hemoptysis: diagnostic and therapeutic insights from a 7-year clinical course.Frontiers in medicine · 2026Article
- Efficacy of bronchial artery embolization in hemoptysis: longitudinal studyon survival and recurrence.CVIR endovascular · 2025Article
- The impact of pulmonary artery invasion on bronchial artery embolization in treating hemoptysis in lung cancer.European journal of radiology open · 2025Article
- Efficacy and safety of CalliSpheres drug-eluting bead bronchial arterial infusion chemoembolization vs. bland embolization in advanced lung cancer with hemoptysis: A multicenter retrospective study.Biomolecules & biomedicine · 2025Article
- Clinical analysis of the efficacy of bronchial artery embolization with gelatin sponge in our hospital for cryptogenic hemoptysis: a single-center, retrospective, observational study.BMC pulmonary medicine · 2025Observational
- Bronchial Artery Embolisation in Haemoptysis Management: A Scoping Review with Emphasis on Embolic Materials and Indications.Advances in respiratory medicine · 2025Article
- The effect of Angio-CT on the efficacy of hemoptysis patients with non-bronchial systemic arteries-a retrospective study.Cardiovascular diagnosis and therapy · 2025Article
- Right bronchial artery aneurysm successfully managed by embolization: Report of a rare case.Radiology case reports · 2025Article
- Bronchial artery embolization for haemoptysis in patients with lymphoma and leukaemia.BJR case reports · 2025Review
- Long term outcomes following embolisation of bronchial and non-bronchial systemic arteries for the management of haemoptysis - a 20-year experience.CVIR endovascular · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess the safety and efficacy of bronchial artery embolization (BAE) for hemoptysis. Methods and materials: Databases with articles published in English, including Pubmed, Embase, Web of science and Chochrane library, were comprehensively searched to get accurate, up-to-date and sufficient literature about BAE for hemoptysis until March 2020. The technical success rates, immediate control rates, recurrence rates, mortality rates, and total complication rates (minor and major complication rates) extracted from the articles were pooled to estimate and assess the efficacy and safety of BAE using random-effect and fixed-effect models. Results: 21 articles published between 2008 and 2019, which include a total of 2511 patients, were studied to evaluate the safety and efficacy of BAE. The technical success and immediate control rates are 99.9% (95%CI: 99%-100%) and 99.5% (95%CI: 97.8%-99.2%), respectively. This study showed hemoptysis recurrence in 23.7% (95%CI: 18.5%-28.9%) with a mortality rate of 2% (95%CI: 0-3%). Additionally, the assessment of complications revealed a total complication rate of 13.4% (95% CI: 7.6-19.2%), in which 0.2% (95% CI: 0.2-0.4%) were major complications and 10% (95% CI: 4.7-9.6%) were minor complications. Conclusion: BAE is an effective, safe, and feasible procedure with a low complication rate for hemoptysis patients. However, recurrence of hemoptysis is still at high risk after BAE due to different underlying diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.